Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|June 9, 2024
Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failureJuliane Rascher, Dan Cotton, Sebastian Haertter, et al.
ERJ Open Research|February 11, 2021
First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteersAlison Mackie, Juliane Rascher, Marion Schmid, et al.
Clinical Pharmacology and Therapeutics|April 16, 2025
Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development PerspectiveRajesh Krishna, Satyendra Suryawanshi, Juliane Rascher, et al.
British Journal of Clinical Pharmacology|May 20, 2025
Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10-17 years with type 2 diabetes mellitusJuliane Rascher, Shen Cheng, Curtis Johnston, et al.
Cancers|June 4, 2020
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid TumorsFilippo de Braud, Jean-Pascal H Machiels, Daniela Boggiani, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and ChallengesJames W T Yates, Michael Zientek, Kunal S Taskar, et al.
Pageof 1